Abstract:The aim of this study is to determine whether vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) could increase the survival of xenografted human ovarian tissue in an experimental rabbit model.Fresh human ovarian tissue was xenotransplanted into the back muscle of 25 castrated female New Zealand rabbits for 6 weeks with the immunosuppression of FTY720 (2 mg/kg/d). Rabbits were randomly divided into five experimental groups: (A) graft and host treatment with VEGF (50 ng/ml); (B) graft and host treatment with bFGF (100 ng/ml); (C) graft and host treatment with VEGF(50 ng/ml) + bFGF (100 ng/ml); (D) graft and host treatment with normal saline; (E) control group, no treatment. 4 weeks after transplantation, human menopausal gonadotropin (HMG) 10 IU was administered every second day in group A, group B, group C and group D for 2 weeks. Graft survival was assessed by graft recovery rate, histological analysis, immunohistochemical staining for CD31 and Ki-67expression, TUNEL assay.After 6 weeks of grafting, the number of CD31-positive stained cells increased significantly in group A, group B and group C compared to the control group. All groups showed strong Ki-67 immunostaining in ovarian stroma. Only one rabbit in group C retained the grafts' follicles. Grafting resulted in relative lower fibrosis in group A and group C compared to the control group. Apoptosis was significantly lower in group C compared to the control group.Fresh human ovarian cortex grafted into the back muscle of rabbit can sustain part of ovarian tissue function with the immunosuppression of FTY720, although follicle number diminishes significantly after grafting. The administration of VEGF and bFGF, especially the combination of them, may trigger angiogenesis, reduce apoptosis and fibrosis, increase survival in transplanted human ovarian tissue.

Research Progress of Human Ovarian Tissue Xenograft Model

Influencing factors and research progress of the human ovarian tissue xenotransplantation

Effects of Graft Thickness on Xenotransplantation of Human Ovarian Tissue in Rabbit Model

The application prospect in oncofertility and existing problems of ovarian tissue cryopreservation and transplantation

Progress in researches on ovarian tissue cryopreservation-transplantation to preserve fertility of the woman

VEGF and Bfgf Increase Survival of Xenografted Human Ovarian Tissue in an Experimental Rabbit Model

Assessment of the Effect of Different Vitrification Solutions on Human Ovarian Tissue after Short-Term Xenotransplantation Onto the Chick Embryo Chorioallantoic Membrane

Melatonin and Ovarian Tissue Transplantation: Current Frontiers in Research

Fertility preservation treatment in patients with epithelial ovarian cancer

The Essential Factors of Establishing Patient-derived Tumor Model.

Prospects for fertility preservation: the ovarian organ function reconstruction techniques for oogenesis, growth and maturation in vitro

Artificial Ovary for Young Female Breast Cancer Patients

[Fertility preservation through natural and artificial ovaries: a review]

Advances in clinical treatment of ovary aging

Xenogeneic stem cell transplantation: Research progress and clinical prospects

Comparison of the different animal modeling and therapy methods of premature ovarian failure in animal model

Progress in the Application of Ovarian and Fallopian Tube Organoid

Research Progress on New Methods to Prevent and Treat Ovarian Senescence: A Review

Recent advances in the field of ovarian tissue cryopreservation and opportunities for research

The Effects of VEGF and bFGF on Ovarian Tissue Transplantation in Mice

Research Progress of the Establishment of Animal Models of Premature Ovarian Failure